• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨甲环酸可能对患有血友病的髋关节/膝关节置换术患者有益。

Tranexamic acid may benefit patients undergoing total hip/knee arthroplasty because of haemophilia.

机构信息

Department of Orthopedic Surgery, West China Hospital, West China Medical School, SiChuan University, 37# Wainan GuoXue Road, ChengDu, SiChuan Province, People's Republic of China.

Department of Radiology, West China Hospital, West China Medical School, SiChuan University, ChengDu, SiChuan Province, People's Republic of China.

出版信息

BMC Musculoskelet Disord. 2019 Sep 4;20(1):402. doi: 10.1186/s12891-019-2767-x.

DOI:10.1186/s12891-019-2767-x
PMID:31481049
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6724260/
Abstract

BACKGROUND

The lower limb joints, including hip and knee, are the most commonly involved joints in haemophilic arthropathy. With a higher risk of transfusion, total hip and knee arthroplasty (THA and TKA) are still the first choice after failure of conservative treatment. In the present study, we aimed to analyze clinical outcomes and complications rate after total joint arthroplasty of the lower limbs using tranexamic acid (TXA) or not.

METHODS

Thirty-four patients with haemophilia A undergoing 24 TKA and 18 THA were evaluated in this retrospective study (No. 201302009). Based on using TXA or not, they were divided into either TXA (12 knees and 10 hips) or Non-TXA groups (12 knees and 8 hips). Total blood loss, intraoperative blood loss, total amount of FVIII usage, range of motion, inflammatory biomarkers, joint function, pain status, complication rate and patient satisfaction were assessed and compared at a mean follow-up of 68 months.

RESULTS

Usage of TXA can decrease not only the perioperative blood loss (p = 0.001), transfusion rate (p = 0.017) and supplemental amount of FVIII (p < 0.001) but also swelling ratio, surgical joint pain. Moreover, compared with non-TXA group, the patients in TXA group had a lower level of inflammatory biomarkers and better joint function.

CONCLUSION

The hemophiliacs treated with TXA had less perioperative blood loss, hidden blood loss, transfusion rate, a lower ratio of postoperative knee swelling, less postoperative joint pain, lower levels of inflammatory biomarkers and better joint function. Further studies need performing to assess the long-term effects of TXA in these patients.

摘要

背景

下肢关节(包括髋关节和膝关节)是血友病性关节病中最常受累的关节。由于需要更高的输血风险,全髋关节和膝关节置换术(THA 和 TKA)仍然是保守治疗失败后的首选治疗方法。在本研究中,我们旨在分析使用或不使用氨甲环酸(TXA)进行下肢关节全关节置换术后的临床结果和并发症发生率。

方法

在这项回顾性研究中,评估了 34 名接受 24 例 TKA 和 18 例 THA 的血友病 A 患者(编号 201302009)。根据是否使用 TXA,他们被分为 TXA 组(12 个膝关节和 10 个髋关节)或非-TXA 组(12 个膝关节和 8 个髋关节)。在平均 68 个月的随访中,评估并比较了总失血量、术中失血量、FVIII 使用总量、关节活动度、炎症生物标志物、关节功能、疼痛状况、并发症发生率和患者满意度。

结果

使用 TXA 不仅可以减少围手术期失血(p=0.001)、输血率(p=0.017)和补充 FVIII 的量(p<0.001),还可以减少肿胀比率和手术关节疼痛。此外,与非-TXA 组相比,TXA 组患者的炎症生物标志物水平更低,关节功能更好。

结论

接受 TXA 治疗的血友病患者围手术期失血、隐性失血、输血率、术后膝关节肿胀比例、术后关节疼痛、炎症生物标志物水平和关节功能均较低。需要进一步研究来评估 TXA 在这些患者中的长期效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fc2/6724260/75296ca05853/12891_2019_2767_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fc2/6724260/60a8dfae7b0d/12891_2019_2767_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fc2/6724260/4cab8e20e5dc/12891_2019_2767_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fc2/6724260/36861a277689/12891_2019_2767_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fc2/6724260/471fb1bfe64f/12891_2019_2767_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fc2/6724260/b575910e443f/12891_2019_2767_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fc2/6724260/75296ca05853/12891_2019_2767_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fc2/6724260/60a8dfae7b0d/12891_2019_2767_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fc2/6724260/4cab8e20e5dc/12891_2019_2767_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fc2/6724260/36861a277689/12891_2019_2767_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fc2/6724260/471fb1bfe64f/12891_2019_2767_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fc2/6724260/b575910e443f/12891_2019_2767_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fc2/6724260/75296ca05853/12891_2019_2767_Fig6_HTML.jpg

相似文献

1
Tranexamic acid may benefit patients undergoing total hip/knee arthroplasty because of haemophilia.氨甲环酸可能对患有血友病的髋关节/膝关节置换术患者有益。
BMC Musculoskelet Disord. 2019 Sep 4;20(1):402. doi: 10.1186/s12891-019-2767-x.
2
Multiple Boluses of Intravenous Tranexamic Acid to Reduce Hidden Blood Loss After Primary Total Knee Arthroplasty Without Tourniquet: A Randomized Clinical Trial.多次静脉注射氨甲环酸以减少无止血带的初次全膝关节置换术后隐性失血:一项随机临床试验
J Arthroplasty. 2016 Nov;31(11):2458-2464. doi: 10.1016/j.arth.2016.04.034. Epub 2016 May 6.
3
Intraarticular use of tranexamic acid reduces blood loss and transfusion rate after primary total knee arthroplasty.关节内使用氨甲环酸可减少初次全膝关节置换术后的出血量和输血率。
BMC Musculoskelet Disord. 2019 Jul 27;20(1):341. doi: 10.1186/s12891-019-2715-9.
4
Intravenous and subsequent long-term oral tranexamic acid in enhanced-recovery primary total knee arthroplasty without the application of a tourniquet: a randomized placebo-controlled trial.静脉注射和随后的长期口服氨甲环酸在不使用止血带的强化康复初次全膝关节置换术中的应用:一项随机安慰剂对照试验。
BMC Musculoskelet Disord. 2019 Oct 25;20(1):478. doi: 10.1186/s12891-019-2885-5.
5
[Local Application of Tranexamic Acid in Total Hip Arthroplasty Decreases Blood Loss and Consumption of Blood Transfusion].氨甲环酸局部应用于全髋关节置换术可减少失血及输血用量
Acta Chir Orthop Traumatol Cech. 2017;84(4):254-262.
6
Tranexamic acid or epsilon-aminocaproic acid in total joint arthroplasty? A randomized controlled trial.氨甲环酸或 ε-氨基己酸用于全关节置换术?一项随机对照试验。
Bone Joint J. 2019 Sep;101-B(9):1093-1099. doi: 10.1302/0301-620X.101B9.BJJ-2018-1096.R1.
7
A comparative, retrospective study of peri-articular and intra-articular injection of tranexamic acid for the management of postoperative blood loss after total knee arthroplasty.一项关于关节周围和关节内注射氨甲环酸用于全膝关节置换术后失血管理的比较性回顾性研究。
BMC Musculoskelet Disord. 2016 Oct 19;17(1):438. doi: 10.1186/s12891-016-1293-3.
8
Effect of knee flexion position and combined application of tranexamic acid on blood loss following primary total knee arthroplasty: a prospective randomized controlled trial.膝关节屈曲位及氨甲环酸联合应用对初次全膝关节置换术后失血的影响:一项前瞻性随机对照试验
Int Orthop. 2018 Mar;42(3):529-535. doi: 10.1007/s00264-018-3808-z. Epub 2018 Feb 2.
9
Intra-articular injection of tranexamic acid in patients with haemophilia arthritis: retrospective controlled study in total knee arthroplasty.关节内注射氨甲环酸治疗血友病性关节炎:全膝关节置换术的回顾性对照研究。
Int Orthop. 2024 Mar;48(3):683-692. doi: 10.1007/s00264-023-05983-8. Epub 2023 Sep 23.
10
Assessment of the effect of addition of 24 hours of oral tranexamic acid post-operatively to a single intraoperative intravenous dose of tranexamic acid on calculated blood loss following primary hip and knee arthroplasty (TRAC-24): a study protocol for a randomised controlled trial.评估在初次髋关节和膝关节置换术中单次静脉注射氨甲环酸后术后加用24小时口服氨甲环酸对计算失血的影响(TRAC-24):一项随机对照试验的研究方案
Trials. 2018 Jul 31;19(1):413. doi: 10.1186/s13063-018-2784-3.

引用本文的文献

1
Normal Haemostasis, Inherited Bleeding Disorders and Surgery: What Does the Anaesthesiologist Need to Know?正常止血、遗传性出血性疾病与手术:麻醉医生需要了解什么?
Medicina (Kaunas). 2025 Jun 13;61(6):1087. doi: 10.3390/medicina61061087.
2
Clinical outcomes of total hip and knee arthroplasty for end-stage hemophilic arthropathy in patients with hemophilia: a retrospective study.血友病患者终末期血友病性关节病全髋关节和全膝关节置换术的临床结局:一项回顾性研究。
J Orthop Surg Res. 2025 May 27;20(1):519. doi: 10.1186/s13018-025-05924-8.
3
Total Hip Arthroplasty for Avascular Necrosis in a Patient With Hemophilia B.

本文引用的文献

1
Effect of Multiple Doses of Oral Tranexamic Acid on Haemostasis and Inflammatory Reaction in Total Hip Arthroplasty: A Randomized Controlled Trial.口服氨甲环酸多次给药对全髋关节置换术止血和炎症反应的影响:一项随机对照试验。
Thromb Haemost. 2019 Jan;119(1):92-103. doi: 10.1055/s-0038-1676625. Epub 2018 Dec 31.
2
Tranexamic acid suppresses the release of mitochondrial DAMPs and reduces lung inflammation in a murine burn model.氨甲环酸抑制线粒体 DAMPs 的释放,并减轻鼠烧伤模型中的肺部炎症。
J Trauma Acute Care Surg. 2019 Apr;86(4):617-624. doi: 10.1097/TA.0000000000002177.
3
Advances and innovations in haemophilia treatment.
乙型血友病患者股骨头缺血性坏死的全髋关节置换术
Arthroplast Today. 2024 Oct 12;30:101482. doi: 10.1016/j.artd.2024.101482. eCollection 2024 Dec.
4
Perioperative bleeding control in total hip arthroplasty: hemostatic powder vs. tranexamic acid-a prospective randomized controlled trial.全髋关节置换术围手术期出血控制:止血粉与氨甲环酸的比较——一项前瞻性随机对照试验。
Arch Orthop Trauma Surg. 2024 Aug;144(8):3797-3805. doi: 10.1007/s00402-024-05475-3. Epub 2024 Aug 6.
5
Morphological Measurement and Clinical Significance of Abnormal Development of Distal Femur with Hemophilia Knee Arthritis: A Consideration on the Renewal of Total Knee Prosthesis.血友病性膝关节炎时股骨远端异常发育的形态学测量及其临床意义:对全膝关节置换假体翻修的思考。
Orthop Surg. 2024 Nov;16(11):2661-2670. doi: 10.1111/os.14170. Epub 2024 Aug 6.
6
The effect of triple-dose-intravenous tranexamic acid on blood loss in patients undergoing total hip arthroplasty without affecting blood coagulopathy: A prospective thromboelastographic analysis.三联剂量静脉注射氨甲环酸对全髋关节置换术患者失血的影响且不影响凝血功能障碍:一项前瞻性血栓弹力图分析。
Acta Orthop Traumatol Turc. 2023 Nov 21;57(6):378-83. doi: 10.5152/j.aott.2023.23001.
7
Primary total knee arthroplasty in hemophilic arthropathy.血友病性关节病的初次全膝关节置换术。
EFORT Open Rev. 2023 Nov 1;8(11):830-840. doi: 10.1530/EOR-23-0101.
8
Intra-articular injection of tranexamic acid in patients with haemophilia arthritis: retrospective controlled study in total knee arthroplasty.关节内注射氨甲环酸治疗血友病性关节炎:全膝关节置换术的回顾性对照研究。
Int Orthop. 2024 Mar;48(3):683-692. doi: 10.1007/s00264-023-05983-8. Epub 2023 Sep 23.
9
Total Hip Arthroplasty in Patients with Hemophilia: What Do We know?血友病患者的全髋关节置换术:我们了解什么?
Arch Bone Jt Surg. 2023;11(7):434-440. doi: 10.22038/ABJS.2023.58812.291.
10
Short-term outcome of total knee replacement in a patient with hemophilia: A case report and review of literature.血友病患者全膝关节置换术的短期疗效:病例报告及文献复习
World J Clin Cases. 2023 Apr 26;11(12):2788-2795. doi: 10.12998/wjcc.v11.i12.2788.
血友病治疗的进展与创新。
Nat Rev Drug Discov. 2018 Jul;17(7):493-508. doi: 10.1038/nrd.2018.70. Epub 2018 Jun 8.
4
Intravenous and Topical Tranexamic Acid Alone Are Superior to Tourniquet Use for Primary Total Knee Arthroplasty: A Prospective, Randomized Controlled Trial.静脉注射和局部应用氨甲环酸在初次全膝关节置换术中优于使用止血带:一项前瞻性随机对照试验。
J Bone Joint Surg Am. 2017 Dec 20;99(24):2053-2061. doi: 10.2106/JBJS.16.01525.
5
Long-term outcome of total hip arthroplasty in patients with haemophilia.血友病患者全髋关节置换术的长期疗效
Haemophilia. 2017 Jan;23(1):129-134. doi: 10.1111/hae.13045. Epub 2016 Aug 1.
6
Multiple Boluses of Intravenous Tranexamic Acid to Reduce Hidden Blood Loss After Primary Total Knee Arthroplasty Without Tourniquet: A Randomized Clinical Trial.多次静脉注射氨甲环酸以减少无止血带的初次全膝关节置换术后隐性失血:一项随机临床试验
J Arthroplasty. 2016 Nov;31(11):2458-2464. doi: 10.1016/j.arth.2016.04.034. Epub 2016 May 6.
7
Does Hemophilia Increase the Risk of Postoperative Blood Transfusion After Lower Extremity Total Joint Arthroplasty?血友病会增加下肢全关节置换术后输血的风险吗?
J Arthroplasty. 2016 Jul;31(7):1578-82. doi: 10.1016/j.arth.2016.01.012. Epub 2016 Jan 21.
8
Complications After TKA in Patients With Hemophilia or Von Willebrand's Disease.血友病或血管性血友病患者全膝关节置换术后的并发症
J Arthroplasty. 2015 Dec;30(12):2285-9. doi: 10.1016/j.arth.2015.06.015. Epub 2015 Jun 12.
9
Outcome after total knee arthroplasty in haemophilic patients with stiff knees.血友病性膝关节僵硬患者全膝关节置换术后的结果
Haemophilia. 2015 Jul;21(4):e300-5. doi: 10.1111/hae.12698. Epub 2015 Apr 30.
10
Combination of intravenous and topical application of tranexamic acid in primary total knee arthroplasty: a prospective randomized controlled trial.静脉和局部联合应用氨甲环酸在初次全膝关节置换术中的应用:一项前瞻性随机对照试验。
J Arthroplasty. 2014 Dec;29(12):2342-6. doi: 10.1016/j.arth.2014.05.026. Epub 2014 Jun 5.